ASPIRIN AND DIPYRIDAMOLE (asprin and extended-release dipyridamole) by Glenmark Pharms Ltd is cyclooxygenase inhibitors [moa]. Approved for stroke in patients, completed ischemic stroke due to thrombosis, completed ischemic stroke due to thrombosis (). First approved in 2019.
Drug data last refreshed 14h ago
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug
Worked on ASPIRIN AND DIPYRIDAMOLE at Glenmark Pharms Ltd? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.